Specifications Compound: Retatrutide (triple agonist GLP-1 / GIP / glucagon) Quantity: 40 mg per vial, lyophilized powder (bulk) Purity: 99%+ HPLC standard batch-specific Certificate of Analysis included for your exact lot Identity: confirmed by LC-MS Appearance: white lyophilized powder Documentation: Every vial ships with access to a batch-specific Certificate of Analysis showing HPLC purity, mass-spectrometry identity confirmation, endotoxin, residual solvents, and water content for your exact lot
Guides on how to reconstitute tirzepatide help ensure proper preparation, and resources on tirzepatide storage and refrigeration are critical for maintaining potency
PMID: 2753890
Lu, Y., Zhang, X., He, J., Dai, Z., Shi, P., Lu, Y., & Chang, F
Ethics declarations Competing interests Through M.H.H.K., the VU University Medical Center has received research grants from AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Sanofi
Cagrilintide as a standalone compound is even earlier in the pipeline it remains at the Phase 2 stage
